Status:
COMPLETED
The Ideal Deep Venous Thrombosis (DVT) Study
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Postthrombotic Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the Netherlands, 25.000 patients each year are diagnosed with Deep Venous Thrombosis (DVT). Elastic compression stocking (ECS) therapy reduces the incidence of post thrombotic syndrome (PTS) follow...
Eligibility Criteria
Inclusion
- Legal age (18 yrs)
- Informed consent
- Acute objectively documented DVT of the leg
- Adequate anticoagulation
Exclusion
- Previous DVT in the affected leg
- Recurrent DVT in the first 6 months following inclusion
- Preexistent venous insufficiency (skin signs C4-C6 on CEAP score or requiring ECS therapy)
- Contraindication for elastic compression therapy (arterial insufficiency)
- Active thrombolysis
- Life expectancy \< 6 months
Key Trial Info
Start Date :
March 22 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
865 Patients enrolled
Trial Details
Trial ID
NCT01429714
Start Date
March 22 2011
End Date
July 1 2017
Last Update
April 10 2018
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera di Padova
Padua, Italy, 35128
2
Treviso Aziende
Treviso, Italy
3
Flevohospital
Almere Stad, Netherlands, 1315 RA
4
VU Medical Centre
Amsterdam, Netherlands, 1007 MB